Does Rallies show 13F holders for NTRA?

Yes. Rallies tracks hedge fund and 13F ownership data for NTRA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is NTRA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NTRA. It does not provide personalized investment advice.

NTRA (Natera, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Natera, Inc. Common Stock (NTRA) is a publicly traded Healthcare sector company. As of May 20, 2026, NTRA trades at $204.16 with a market cap of $27.57B and a P/E ratio of -124.56. NTRA moved +4.51% today. Year to date, NTRA is -13.69%; over the trailing twelve months it is +32.61%. Its 52-week range spans $117.27 to $256.36. Analyst consensus is strong buy with an average price target of $262.14. Rallies surfaces NTRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns NTRA stock?

Hedge funds tracked by Rallies that own NTRA include Farallon Capital, Duquesne Family, Coatue Management, Maverick Capital, and Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Natera, Inc. Common Stock.

NTRA Key Metrics

Key financial metrics for NTRA
Metric	Value
Price	$204.16
Market Cap	$27.57B
P/E Ratio	-124.56
EPS	$-1.62
Dividend Yield	0.00%
52-Week High	$256.36
52-Week Low	$117.27
Volume	1.33M
Avg Volume	0
Revenue (TTM)	$2.50B
Net Income	$-226.31M
Gross Margin	0.00%

Top Hedge Funds Holding NTRA

Farallon Capital holds 3.21M shares of NTRA, changed -18.06% as of Mar 31, 2026.
Duquesne Family holds 3.06M shares of NTRA, changed +21.99% as of Mar 31, 2026.
Coatue Management holds 2.54M shares of NTRA, changed -51.74% as of Mar 31, 2026.
Maverick Capital holds 1.17M shares of NTRA, changed +24.11% as of Mar 31, 2026.
Orbimed Advisors holds 262.00K shares of NTRA, changed -28.38% as of Mar 31, 2026.

Latest NTRA News

Natera Q1 Revenues Surge 38.8% to $696.6 Million with 64.7% Margin — May 7, 2026
Natera rises ahead of May 7 earnings as expectations build and targets lift — May 6, 2026
Tempus AI Q1 Revenue Up 36% to $348M, Data Unit Drives 73% Margin — May 6, 2026
Natera climbs 3% as traders position for Q1 earnings, bullish targets resurface — Apr 30, 2026
Natera drops 3.5% as risk-off trade and class-action overhang pressure shares — Apr 29, 2026

Recent NTRA Insider Trades

Sheena Jonathan sold 85 (~$16.96K) on May 13, 2026.
Sheena Jonathan sold 345 (~$69.38K) on May 13, 2026.
Sheena Jonathan sold 290 (~$58.75K) on May 13, 2026.

NTRA Analyst Consensus

16 analysts cover NTRA: 0 strong buy, 15 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $262.14.

Common questions about NTRA

Who owns NTRA stock?: Hedge funds tracked by Rallies that own NTRA include Farallon Capital, Duquesne Family, Coatue Management, Maverick Capital, and Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Natera, Inc. Common Stock.
Does Rallies show 13F holders for NTRA?: Yes. Rallies tracks hedge fund and 13F ownership data for NTRA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NTRA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NTRA. It does not provide personalized investment advice.